Hyperemesis Gravidarum Clinical Trial
Official title:
Use of the Modified PUQE ( Pregnancy -Unique Quantification of Emesis ) Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment
NCT number | NCT04785911 |
Other study ID # | 17101318 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | September 5, 2021 |
Est. completion date | November 1, 2022 |
Verified date | April 2023 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Use of the PUQE score to judge the need for admission in cases of hyperemesis gravidarum Evaluation of the response to treatment by the PUQE score
Status | Completed |
Enrollment | 200 |
Est. completion date | November 1, 2022 |
Est. primary completion date | October 1, 2022 |
Accepts healthy volunteers | |
Gender | Female |
Age group | 16 Years to 46 Years |
Eligibility | Inclusion Criteria: - women hospitalized due to hyperemesis gravidarum with at least two out of three criteria; dehydration, weight loss > 5% of prepregnancy weight (if known) or electrolyte imbalance/ketonuria. - Gestational age between 6_16 weeks. Exclusion Criteria: 1. Women Suffered from other diseases causing nausea and vomiting : - gastritis - renal diseases - Hepatic disorders - Throid disorders 2. the gestational length was more than 16 weeks at inclusion. |
Country | Name | City | State |
---|---|---|---|
Egypt | Tasnem iIbrahem Aboelouon | Assiut | Assuit |
Lead Sponsor | Collaborator |
---|---|
Tasnem Abo-elouon | Assiut University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Detect improvement of patients by 1- daily scor of PUQE score 2-BMI by kg/m2 change from day of admission to day of discharge | We can assess severity and change by daily score which detected by daily PUQE score and pre gestational BMI by kg/m2 and BMI by kg/m2 of pregenent women with hyperemisis from day of admission to hospital to day of discharge To descripe the PUQE score full text with scoring range will be attached Total score is sum of replies to each of the three questions. PUQE-24 score: Mild = 6; Moderate = 7-12; Severe = 13-15.
Motherisk PUQE-24 scoring system the last 24 hours, for how long have you Felt nauseated or sick to your stomach? Not at all (1 ) 1hour or less (2) 2-3 hours(3) 4-6 hours (4) More than 6 hours (5) In the last 24 hours have you vomited Or thrown up? 7 or more Times (5) 5-6 times (4) 3-4 times(3). 1-2 times(2) I did not throw up (1) In the last 24 hours how many times Have you had retching or dry heaves Without bringing anything up? No time (1) 1-2 times(2) 3-4 times(3) 5-6 times (4) 7 or more times (5) |
Basline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT04719286 -
MinSafeStart - Decision Aid Tool for Better Treatment of Nausea and Vomiting During Pregnancy
|
N/A | |
Completed |
NCT02300155 -
Improving Multivitamin Supplementation to Pregnant Women
|
Phase 4 | |
Completed |
NCT05175079 -
Acupressure in Hyperemesis Gravidarum
|
N/A | |
Completed |
NCT05098067 -
Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy
|
Phase 2 | |
Completed |
NCT01836835 -
Pregnancy Specific Nausea Questionnaire (PUQE) Translated and Tested in Norwegian
|
N/A | |
Completed |
NCT03950167 -
Gallbladder Functions & Serum Cholecystokinin Levels in Women Diagnosed With Hyperemesis Gravidarum
|
||
Completed |
NCT02830321 -
The Association of Helicobacter Pylori in the Pathogenesis of Hyperemesis Gravidarum in Pregnant Women
|
N/A | |
Completed |
NCT02541682 -
Assessment of the Relationship Between Affective Temperament and the Severity of Nausea and Vomiting in Early Pregnancy
|
N/A | |
Terminated |
NCT03785691 -
Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum
|
Phase 2 | |
Completed |
NCT05446025 -
The Levels of the Orexin, Galanin and aMSH and CART in Patients With Hyperemesis Gravidarum
|
||
Recruiting |
NCT02862496 -
Bone Health in Hyperemesis Gravidarum
|
N/A | |
Completed |
NCT02163434 -
Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum
|
Phase 2 | |
Terminated |
NCT05452174 -
Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP)
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06442813 -
Effects Of Emotional Freedom Technique and Hypermesis Gravidarum
|
N/A | |
Completed |
NCT06245811 -
Inflammation Markers in Hyperemesis Gravidarum
|
||
Recruiting |
NCT06266819 -
The Effect of Mint Flavored Chewing Gum on Hyperemesis Gravidarum Nausea Vomiting Severity, Coping With Stress and Anxiety Level in Pregnants With Hyperemesis Gravidarum
|
N/A | |
Completed |
NCT04828967 -
Use of Hypnosis in Hyperemesis Gravidarum
|
N/A | |
Completed |
NCT03127293 -
Hyperemesis Gravidarum and Osteoporosis
|
N/A | |
Completed |
NCT01559012 -
Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum
|
Phase 3 |